STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
32 hedge funds and large institutions have $264M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.27M | |
| 2 | +$2.04M | |
| 3 | +$1.65M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.27M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.16M |
Top Sellers
| 1 | -$5.01M | |
| 2 | -$4.16M | |
| 3 | -$1.25M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$938K |
| 5 |
DIM
DC Investments Management
Mclean,
Virginia
|
-$533K |